Main Session
Sep
30
SH 07 - Head and Neck Cancer - Science Highlights
173 - C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival
Presenter(s)
Gerard Adams, MB, ChB, FRANZCR - Genesis Care Bundaberg, Bundaberg, QLD